Zentiva Sees Ninefold Increase In Q1 Profit To Over RON42M

05.16.2023 By Ecaterina Craciun

Pharmaceutical company Zentiva SA had a turnover of RON230 million in January-March 2023, up 36% on the year, and a profit of over RON42 million, almost nine times higher than RON5 million reported in Jan-March 2022, as per data from the company's quarterly financial report published at the Bucharest Stock Exchange.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:: Zentiva; , earnings

Comment

Username:
Password: